| 251.2 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | |
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | |
| 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | |
| 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | |
| 12494 | AUGMENTIN 1GM | tbl 14x1gm | SKB | GB |
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 |
| 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A |
| 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 |
| 84792 | AUGMENTIN DUO | plv sus 1x70ml | SKW | GB |
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB |
|---|
| 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2 | GM | 162,17 | U/ATB |
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 109,88 | U/ATB |
| 97660 | AUGMENTIN 1,2GM | inj sic 5x1.2gm | LEX | CZ |
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB |
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB |
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U |
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB |
| 253 | J01DA | cefalosporinová antibiotika | p.o. |
|---|
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 |
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A |
| 06158 | ORACEF | cps 16x500mg | KRK | SLO |
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A |
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A |
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A |
| 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 92,35 |
| 76366 | ZINNAT | tbl fc 10x125mg | GLA | I |
| 76367 | ZINNAT | tbl fc 10x250mg | GLA | I |
| 76368 | ZINNAT | tbl fc 10x500mg | GLA | I |
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 |
| 96016 | ZINNAT | gra sus 1x50ml | GLA | GB |
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 72,88 |
| 53153 | VERCEF 250 MG | cps 7x3 (blistr) | RXY | IND |
| 69474 | CECLOR RETARD 375MG | tbl obd 10x375mg | LIL | I |
| 253.6 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 66,03 |
| 53157 | VERCEF 500 MG | cps 7x3 (blistr) | RXY | IND |
| 69475 | CECLOR RETARD 750MG | tbl obd 10x750mg | LIL | I |
| 45193 | CEC 500 | tbl obd 10x500mg | SFS | D |
| 45194 | CEC 500 | tbl obd 20x500mg | SFS | D |
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 103,11 |
| 45195 | CEC SIRUP | plv sus 100ml/2.5gm | SFS | D |
| 253.8 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 |
| 53152 | VERCEF250 MG/5ML | plv sus 1x100 ml | RXY | IND |
| 45196 | CEC FORTE SIRUP | plv sus 100ml/5gm | SFS | D |
| 253.9 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 44,00 |
| 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A |
| 44799 | BIODROXIL | cps 12x500mg | BCA | A |
| 46752 | CEFADROX TABS | tbl sol 10x1000mg | SFS | D |
| 46753 | CEFADROX TABS | tbl sol 20x1000mg | SFS | D |
| 253.10 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 68,00 |
| 44807 | BIODROXIL 250MG/5ML | plv sus 1x60ml/3gm | BCA | A |
| 253.11 | J01DA23 | cefixim | p.o. | 0.4 | GM | 107,35 | ATB |
| 253.12 | J01DA26 | cefetamet | p.o. | 1 | GM | 107,53 | ATB |
| 253.13 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.14 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.15 | J01DA41 | cefprozil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 253.16 | J01DA41 | cefprozil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB P |
|---|